[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 35 of about 35
32. Baek SJ, Park JY, Kim DY, Kim JH, Kim YM, Kim YT, Nam JH: Stage IIIC epithelial ovarian cancer classified solely by lymph node metastasis has a more favorable prognosis than other types of stage IIIC epithelial ovarian cancer. J Gynecol Oncol; 2008 Dec;19(4):223-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Stage IIIC epithelial ovarian cancer classified solely by lymph node metastasis has a more favorable prognosis than other types of stage IIIC epithelial ovarian cancer.
  • OBJECTIVE: To verify whether it can be justified to classify patients to stage IIIC epithelial ovarian cancer based on nodal involvement only.
  • METHODS: This study included all consecutive patients with stage IIIC epithelial ovarian cancer who underwent upfront cytoreductive surgery according to the FIGO guideline followed by platinum based chemotherapy from September 1989 to September 2006 at Asan Medical Center.
  • Forty-one patients were allocated to stage IIIC by positive nodes only.
  • Patients with stage IIIC disease due to positive nodes only had significantly longer DFS and OS compared to other stage IIIC patients (p<0.001 and p<0.001).
  • The DFS and OS of these patients was significantly better than those of other stage IIIC patients who achieved complete or optimal cytoreduction (p<0.001 and p<0.001).
  • The outcome was even better than that of stage IIIA and IIIB patients (p<0.05 and p<0.05).
  • CONCLUSION: Patients with stage IIIC epithelial ovarian cancer due to positive nodes only had a more favorable prognosis compared to other stage IIIC patients.
  • Therefore, reevaluation of the current FIGO staging system for stage IIIC epithelial ovarian cancer is required.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Gynecol Oncol. 2007 Oct;107(1):154-6 [17614126.001]
  • [Cites] Gynecol Oncol. 2006 Dec;103(3):781-2 [17141679.001]
  • [Cites] Gynecol Oncol. 2006 Dec;103(3):797-801 [17052746.001]
  • [Cites] CA Cancer J Clin. 2006 Mar-Apr;56(2):106-30 [16514137.001]
  • [Cites] Gynecol Oncol. 1999 May;73(2):237-41 [10329040.001]
  • [Cites] Cancer. 1998 Oct 15;83(8):1555-60 [9781949.001]
  • [Cites] Gynecol Oncol. 1997 Jun;65(3):467-72 [9190977.001]
  • [Cites] N Engl J Med. 1996 Jan 4;334(1):1-6 [7494563.001]
  • [Cites] Gynecol Oncol. 1992 Nov;47(2):159-66 [1468693.001]
  • [Cites] Gynecol Oncol. 1995 Mar;56(3):345-52 [7705667.001]
  • [Cites] Gynecol Oncol. 1994 Oct;55(1):108-10 [7959250.001]
  • [Cites] Am J Obstet Gynecol. 1994 Feb;170(2):656-62 [8116728.001]
  • [Cites] Gynecol Oncol. 1993 Nov;51(2):150-4 [8276287.001]
  • [Cites] Gynecol Oncol. 1991 Feb;40(2):103-6 [2010101.001]
  • [Cites] Eur J Gynaecol Oncol. 1988;9(1):36-9 [3345782.001]
  • [Cites] Gynecol Oncol. 1987 Jul;27(3):368-72 [3623232.001]
  • [Cites] Cancer. 1985 May 1;55(9):2019-25 [3978582.001]
  • [Cites] Obstet Gynecol. 1983 Apr;61(4):413-20 [6828269.001]
  • [Cites] Am J Obstet Gynecol. 1974 Aug 15;119(8):1013-7 [4847438.001]
  • [Cites] Cancer Chemother Rep. 1966 Mar;50(3):163-70 [5910392.001]
  • [Cites] J Clin Oncol. 2002 Mar 1;20(5):1161-3 [11870155.001]
  • (PMID = 19471577.001).
  • [ISSN] 2005-0380
  • [Journal-full-title] Journal of gynecologic oncology
  • [ISO-abbreviation] J Gynecol Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Korea (South)
  • [Other-IDs] NLM/ PMC2676474
  • [Keywords] NOTNLM ; Epithelial ovarian cancer / Lymph node metastasis / Prognosis / Stage IIIC
  •  go-up   go-down


33. Terauchi F, Nishi H, Moritake T, Kobayashi Y, Nagashima T, Onodera T, Fujito A, Nakayama D, Isaka K: Prognostic factor on optimal debulking surgery by maximum effort for stage IIIC epithelial ovarian cancer. J Obstet Gynaecol Res; 2009 Apr;35(2):315-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Prognostic factor on optimal debulking surgery by maximum effort for stage IIIC epithelial ovarian cancer.
  • OBJECTIVES: The aim of this study was to assess the prognostic factor of radical surgery in patients with stage IIIc ovarian cancer.
  • CONCLUSIONS: OPCS should be performed with maximum effort to improve the prognosis of stage IIIc ovarian cancer.
  • [MeSH-major] Neoplasms, Glandular and Epithelial / surgery. Ovarian Neoplasms / surgery


3
Advertisement
4. Nwanodi O, Choi C, Khulpateea N: Cervicovaginal cytology and diagnosis of ovarian or peritoneal cancer: case report and literature review. Arch Gynecol Obstet; 2008 Feb;277(2):171-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cervicovaginal cytology and diagnosis of ovarian or peritoneal cancer: case report and literature review.
  • BACKGROUND: The characteristics of women presenting with asymptomatic ovarian or peritoneal cancer diagnosed following evaluation for abnormal cervicovaginal cytology are currently undefined.
  • CASE: We present a case of a 51-year-old woman with asymptomatic stage IIIC ovarian cancer whose diagnosis was triggered by evaluation for adenocarcinoma and atypical glandular cells of undetermined significance (AGUS) on cervical cytology.
  • We also present a case of a 53-year-old woman with AGUS cervical cytology on two occasions, found to have stage III peritoneal cancer at exploratory laparotomy.
  • CONCLUSION: We conducted a systematic search for articles to enable a review of asymptomatic cases of ovarian and peritoneal cancer, which presented via abnormal cervicovaginal cytology.
  • The mean age at presentation with peritoneal cancer was 47.8 years old, which is similar to that of ovarian cancer of 50.5 years.
  • Staging was provided in 13 cases, 11 of which (85%) were at least stage IIIA or greater.
  • In terms of age greater than 50 years old, cervicovaginal cytology interpreted as AGUS, having a negative initial work-up, and advanced disease stage at presentation, the two cases presented are consistent with the literature.
  • Abnormal cervicovaginal cytology as a presenting diagnostic criterion of cancer of the ovary or peritoneum is often representative of advanced disease.
  • [MeSH-major] Cervix Uteri / pathology. Ovarian Neoplasms / diagnosis. Peritoneal Neoplasms / diagnosis. Vaginal Smears
  • [MeSH-minor] Adenocarcinoma, Papillary / diagnosis. Adenocarcinoma, Papillary / therapy. Carcinoma, Papillary / diagnosis. Female. Humans. Middle Aged. Neoplasm Staging. Precancerous Conditions / pathology


35. Takeyama S, Aoki Y, Kamimura N, Suzuki M, Tanaka K: Retrieval of intraperitoneal Penrose drain under transvaginal endoscopic guidance. Gynecol Oncol; 2006 Aug;102(2):391-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • CASE: A 49-year-old woman with the International Federation of Gynecology and Obstetrics (FIGO) stage IIIc ovarian cancer underwent bilateral salpingo-oophorectomy, total hysterectomy, partial omentectomy, and pelvic and para-aortic lymph nodes removal.
  • [MeSH-major] Drainage / instrumentation. Foreign Bodies / surgery. Ovarian Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Foreign Bodies.
  • MedlinePlus Health Information. consumer health - Ovarian Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16542713.001).
  • [ISSN] 0090-8258
  • [Journal-full-title] Gynecologic oncology
  • [ISO-abbreviation] Gynecol. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down






Advertisement